Actively Recruiting
Blood Sampling of Healthy Volunteers for Immunological Research
Led by The Netherlands Cancer Institute · Updated on 2023-03-23
50
Participants Needed
1
Research Sites
460 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This protocol will be used to collect crucial components of the immune system from healthy volunteers for the characterization of immune cells in fresh blood. A pipeline has been set up for comprehensive immune phenotyping of both lymphoid and myeloid cells within 24 hours after blood withdrawal.
CONDITIONS
Official Title
Blood Sampling of Healthy Volunteers for Immunological Research
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age above 35 years
- Written informed consent
- No history of cancer
- No use of systemic immunosuppressive medication (eg. corticosteroids). Local use of corticosteroids (eg. topical or inhalation) is allowed.
You will not qualify if you...
- Fever 14 days before blood withdrawal
- Donated blood for the same program within the last 2 years
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
NKI-AVL
Amsterdam, Netherlands, 1066CX
Actively Recruiting
Research Team
M
M Kok, MD
CONTACT
L
L Voorwerk, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here